Basic Principles of Cancer Chemotherapy

BASIC PRINCIPLES OF CANCER CHEMOTHERAPY

Overview of Cancer

  • Cancer Definition: Unregulated cellular proliferation
Characteristics of Neoplastic Cells
  • Persistent Proliferation: Cancerous tissues continue to grow until they cause death.
  • Unresponsive to Feedback: Malignant cells do not adhere to the normal feedback mechanisms that regulate cell growth.
  • Frequent Division: They divide more frequently than normal cells, rather than simply dividing more rapidly.
  • Invasive Growth: Malignant cells grow into surrounding tissues.
  • Metastasis: Formation of secondary tumors away from the primary site.
  • Immortality: These cells can proliferate indefinitely.
Causes of Cancer
  • DNA Alterations: Fundamental changes in DNA lead to cancer.
    • Activation of Oncogenes: Genes that promote cell division or survival.
    • Inactivation of Tumor Suppressor Genes: Genes that normally inhibit cell proliferation.
    • Carcinogens: Substances causing cancer, including chemicals, viruses, and radiation.

Treatment Modalities

  • Surgery: Effective for solid tumors.
  • Radiation: Useful for localized tumors.
  • Drug Therapy:
    • Chemotherapy: Primary treatment for disseminated cancers such as leukemia and widespread metastases.
Drug Classes Used in Cancer Treatment
  • Cytotoxic Agents: Often referred to as chemotherapy; directly kill cancer cells.
  • Hormones and Hormone Antagonists: Manipulate hormonal pathways to control cancer growth.
  • Biologic Response Modifiers: Immunomodulating agents that enhance the body’s immune response against cancer.
  • Targeted Drugs: Specifically bind to cancer cell targets to exert therapeutic effects.

Growth Fraction in Tumors

  • Definition: Growth fraction represents the percentage of actively dividing cells relative to resting (G0) cells.
  • Cell Cycle Phases:
    • G1 Phase: Pre-DNA synthesis.
    • S Phase: DNA synthesis phase.
    • G2 Phase: Pre-mitotic phase.
    • M Phase: Mitosis phase.
  • High Growth Fraction: Tissues with a large percentage of proliferating cells, typically respond better to chemotherapy.
  • Low Growth Fraction: Tissues primarily composed of G0 cells show decreased responsiveness.

Relationship of Growth Fraction to Chemotherapy

  • Chemotherapeutic Effects: Most drugs target proliferating cells, disrupting DNA synthesis or mitosis.
  • Chemotherapy Toxicity: Higher toxicity in tissues with high growth fractions such as bone marrow, skin, hair follicles, sperm, and gastrointestinal tract.
Common Types of Cancers and Their Growth Fraction
  • Common Solid Tumors:
    • Breast, lung, prostate, colon, and rectum cancers; generally have low growth fractions and poor response to cytotoxic drugs.
  • Rarer Cancers:
    • Lymphocytic leukemia, Hodgkin’s disease, certain testicular cancers; usually exhibit high growth fractions and good response to chemotherapy.

Challenges in Chemotherapy

Obstacles to Successful Chemotherapy
  • Toxicity to Normal Cells:
    • Lack of selective toxicity makes it difficult to target cancer cells without harming normal cells.
    • A cure requires 100% cell kill, complicating treatment protocols.
    • Symptoms may improve before complete eradication of malignant cells.
  • Host Defenses:
    • The immune system often fails to recognize and destroy cancer cells, necessitating ongoing chemotherapy.
  • Early Detection Issues:
    • Solid tumors often detected late due to low growth rates and high G0 cell percentage.
  • Drug Resistance:
    • Tumor heterogeneity results in a population of cells that can resist treatment.
  • Limited Drug Access:
    • Factors include tumor location, blood supply, and blood-brain barrier complicating drug distribution.

Strategies for Effective Chemotherapy

Achieving Maximum Benefits
  • Intermittent Chemotherapy:
    • Allows normal cells to repopulate faster than cancer cells, targeting a 100% kill of cancer cells while minimizing damage to normal tissues.
  • Combination Chemotherapy:
    • Utilizes multiple drugs to exploit different mechanisms, reducing resistance, increasing cancer cell kill, and minimizing injury to normal cells.
  • Guidelines for Drug Selection:
    • Each drug should be effective alone and have differing mechanisms of action.
    • Minimize overlapping toxicities between drugs.
Dosing Schedules
  • Dosing Strategies:
    • Multiple smaller doses can maximize therapeutic effects and minimize toxicity.
  • Regional Drug Delivery:
    • Intra-arterial Therapy: High drug concentrations near the tumor while reducing systemic side effects.
    • Intrathecal Delivery: Direct delivery bypassing the blood-brain barrier.
    • Other specialized routes may include portal vein and direct bladder administration.

Major Toxicities of Cancer Chemotherapy

Myelosuppression
  • Definition: Bone marrow suppression leading to decreases in blood cell counts.
Consequences of Myelosuppression
  1. Infection risks: Loss of neutrophils increases susceptibility to infections.
    • Signs of Infection: Principal early sign is fever; prompt investigation required (blood cultures, etc.).
  2. Bleeding Risks: Due to lowered platelet counts (thrombocytopenia).
  3. Anemia: Decreased erythrocytes leading to fatigue and weakness.
Treatments for Myelosuppression
  • Neutropenia Management: Granulocyte colony-stimulating factors (Filgrastim, Pegfilgrastim).
  • Thrombocytopenia Treatment: Oprelvekin (Neumega); monitor and avoid invasive procedures if platelets drop below 50,000/mcL.
  • Anemia Treatment: Erythropoietin administration; efficacy in palliative contexts.
Other Toxicities
  • Digestive Tract Injury: High growth fraction leads to issues like stomatitis and diarrhea.
    • Stomatitis Treatment: Mild cases treated with topical anesthetics; severe cases may require systemic opioids.
    • Diarrhea Treatment: Managed with loperamide.
  • Nausea and Vomiting: Common due to stimulation of the chemoreceptor trigger zone.
    • Management: Antiemetic medications should be administered before chemotherapy to reduce severity.
    • Types of Emesis: 1) Anticipatory 2) Acute 3) Delayed.
  • Alopecia & Reproductive Toxicity: Hair loss is common, along with reproductive impacts.
  • Unique Toxicities: Specific chemotherapeutic agents have unique effects (e.g., Daunorubicin on heart, Cisplatin on kidneys, Vincristine on nerves).

PAIN MANAGEMENT IN PATIENTS WITH CANCER

Understanding Pain

  • Definition: Pain is an unpleasant sensory and emotional experience associated with tissue damage.
  • Assessment Method: The most reliable assessment method is patient self-reporting.
  • Types of Pain:
    • Nociceptive Pain: Results from tissue injury.
    • Neuropathic Pain: Results from nerve injury; often requires different analgesic strategies.

Cancer Pain Sources

Causes of Cancer Pain
  • Direct Tumor Effects: Invasion into tissues, metastasis, and pressure on surrounding structures.
  • Treatment Side Effects:
    • Chemotherapy: Causes mucositis and nerve damage.
    • Radiation: May lead to osteonecrosis or neuropathy.
    • Surgery: Can lead to phantom limb pain or chronic pain syndromes.
Barriers to Effective Pain Management
Patient Concerns
  • Fear of addiction, unmanageable side effects, and concerns about being perceived as a “bad patient.”
  • Low priority assigned to cancer pain management due to misconceptions about pain tolerance.
Healthcare System Barriers
  • Insufficient knowledge among providers regarding effective pain management.
  • Regulatory complications with controlled substance prescriptions.
Comprehensive Initial Assessment
  • Objective: Characterize pain and identify causes using self-reports, examinations, and diagnostic tests.
Ongoing Evaluation of Pain
  • Regular reassessment to determine efficacy of treatment and identify new pain sources.
  • Barriers: Patient underreporting and cultural/language discrepancies.

Analgesic Drug Therapy

Types of Analgesics
  • Nonopioid Analgesics: NSAIDs & acetaminophen.
    • Adverse Effects: Gastric ulceration, renal failure.
  • Opioid Analgesics: Strongly effective but risk of dependence. Oxycodone and morphine prioritized for cancer pain.
  • Adjuvant Analgesics: Enhance analgesic effects or treat coexisting symptoms; include antidepressants and anticonvulsants.
WHO Analgesic Ladder Approach
  1. Step 1: Mild to moderate pain—nonopioids.
  2. Step 2: Moderate pain—add opioids.
  3. Step 3: Severe pain—strong opioids.
Managing Side Effects of Opioids
  • Respiratory Depression: Administer Naloxone.
  • Constipation: Utilize laxatives and stool softeners.
  • Nausea: Use antiemetics to manage.

Pain Management in Special Populations

  • Older Adults: Increased sensitivity and risks for side effects; aim for thorough pain management without under-treatment.
  • Children: May experience different pain responses and require careful management strategies.
Patient Education Initiatives
  • Discuss nature and causes of pain, treatment plans, and importance of reporting pain honestly.
  • Address concerns about drug dependence and potential side effects of pain medication.